Aquestive Therapeutics, Inc. (AQST)
NGM · Common · CUSIP 03843E104
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for AQST and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
03843E104
Market Cap
Small Cap
IPO
7/24/2018 · $15.00/share
Business: Aquestive Therapeutics, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs. Aquestive Therapeutics has a late-stage proprietary product pipeline focused on the treatment of CNS diseases, and is working to advance orally-administered complex molecules that it believes can be alternatives to invasively-administered standard of care therapies.

Company Contact

CEO
Daniel Barber
CFO
Ernie Toth
Headquarters
30 Technology Drive, Warren, NJ 07059
Phone
908-941-1900
Investor Relations
Stephanie Carrington, Westwicke · 646-277-1282 · stephanie.carrington@westwicke.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »